Related Experiment Video
Updated: Jun 18, 2025
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!]
Peter Albers1,2, Nikolaus Becker3
1Abteilung für Personalisierte Früherkennung des Prostatakarzinoms, Deutsches Krebsforschungszentrum (DKFZ) Heidelberg, C130, Im Neuenheimer Feld 581, 69120, Heidelberg, Deutschland. p.albers@dkfz-heidelberg.de.
Summary
Germany should update its prostate cancer early detection program. New findings suggest an organized, risk-adapted screening approach, potentially improving outcomes for prostate cancer detection.
Area of Science:
- Oncology
- Public Health
- Screening Programs
Context:
- European Commission recommends novel screening approaches for lung, gastric, and prostate cancers.
- Germany is prompted to revise its existing prostate early detection program.
- Growing evidence supports risk-adapted strategies in cancer screening.
Purpose:
- To discuss new findings on prostate cancer screening.
- To advocate for an organized and risk-adapted screening approach in Germany.
- To propose the establishment of model projects for a revised screening program.
Summary:
- Recent European recommendations and German trial data (PROBASE) suggest a shift towards organized, risk-adapted prostate cancer screening.
- The article reviews new findings supporting this approach.
- Model projects are proposed to define specific modalities for a new German program.
Impact:
- Potential to enhance the effectiveness and efficiency of prostate cancer early detection in Germany.
- Could lead to a more personalized and targeted screening strategy, reducing overdiagnosis and overtreatment.
- Provides a framework for developing evidence-based, organized screening programs for prostate cancer in line with European directives.
Related Concept Videos
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
01:30Preventive Healthcare Services
979
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
979
01:12Hazard Ratio
106
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
106
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347